ArticleRheumatology (Oxford, England)2024

Human genetic evidence supports fibroblast growth factor 21 as a novel therapeutic target for gout.

Sizheng Steven Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.